Reuters - Video

エディション: US | UK | IN | CN | JP

video

WHO pauses hydroxychloroquine trial over safety concerns

2020年 5月 26日 Tuesday - 01:02

The World Health Organization has suspended testing the malaria drug hydroxychloroquine in COVID-19 patients due to safety concerns, WHO Director General Tedros Adhanom Ghebreyesus said on Monday. Gavino Garay has more.

▲ ストーリーを隠す

ストーリーを表示する

The World Health Organization has suspended testing the malaria drug hydroxychloroquine in COVID-19 patients due to safety concerns, WHO Director General Tedros Adhanom Ghebreyesus said on Monday. Gavino Garay has more.

リンクをコピーするには:URL上で右クリック後「コピー」を選択。モバイル端末では、URLを長押ししてください。

WHO pauses hydroxychloroquine trial over safety concerns

2020年 5月 26日 Tuesday - 01:02